VRDN fund manager activity
Viridian Therapeutics, Inc · Nasdaq. Reported by 2 tracked fund managers in their 13F filings, Q4 2023 to Q2 2026.
Q2 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Ken Fisher - Fisher Asset Management | Trimmed | 1,750,850 | $32,163,113 | 0.01% | Aug 4, 2026 |
Q1 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Ken Fisher - Fisher Asset Management | Trimmed | 1,768,295 | $34,587,849 | 0.01% | May 5, 2026 |